InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: Amatuer17 post# 113723

Wednesday, 08/02/2017 9:04:48 PM

Wednesday, August 02, 2017 9:04:48 PM

Post# of 463333
Yes. The most recent addition to the Advisory Board commented that there are three trials set to begin soon. He is privy to more information, and the newest data, compared to what has been publicly made available. So I trust him at his word as he would have no reason to flat out lie in a press release.

How do we know that there isn't bad news? We don't. But how do we know there isn't good news around the corner, either? You have to ask yourself why would a Harvard MD join the SAB if the data weren't good -- I suppose it's possible he or she is willing to sacrifice reputation for a small salary, but typically these SAB members are paid out in shares of common stock. So again, why would he or she agree to join if the data weren't good. Why wouldn't we see other SAB members leaving if the stock options they receive are going to be worthless?

CITX was a Phase 1 trial. We have positive data going into over year of Phase 2. It's all but certain we'll get to P3 -- from there it's anyone's guess, but I certainly wouldn't want to be short when the P3 announcement is made.

I'm sure you'll find some sort of retort or way to skew what I just wrote. That's fine. Everyone here knows your agenda so you may as well be open about it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News